Companies sponsors |
Leith Healthcare |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
Professional groups |
British Association of Dermatologists |
|
British Dermatological Nursing Group |
|
Primary Care Dermatology Society |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal College of Surgeons |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
UK Clinical Pharmacy Association |
Assessment group |
BMJ Group |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
Abbvie (botulinum toxin type A) |
|
Aspire Pharma (prolonged-release oxybutynin) |
|
Croma Pharma (botulinum toxin type A) |
|
Dawa (glycopyrronium bromide) |
|
Evolus International (botulinum toxin type A) |
|
Galderma (botulinum toxin type A) |
|
Grünenthal Meds (propantheline bromide) |
|
Merz Aesthetics (botulinum toxin type A) |
|
Morningside Healthcare (glycopyrronium bromide) |
|
Neon Healthcare (oxybutynin) |
|
Tillomed laboratories (oxybutynin) |
|
Strandhaven Limited t/a Somex Pharma (glycopyrronium bromide) |
|
Strides Pharma (oxybutynin) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Department of Health - Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
British Skin Foundation |
|
Cochrane Skin Group |
|
Genomics England |
|
MRC Clinical Trials Unit |
|
National Institute for Health Research |